RTSN dilution watch: offerings and filings

RTSN (Retension Pharmaceuticals, Inc.) filed a new prospectus supplement (424B) on Friday, October 9, 2026 (S-1). Below is every offering event for the name in the last 60 days, newest first, and its Momo Meter alert history: 2 alerts in 90 days, last Oct 19, 3:48 PM.

DateEventMomo Meter alerts, 90 days
Oct 9, 2026New 424B filed a new prospectus supplement (424B), S-1, ipo2 last Oct 19, 3:48 PM
Oct 9, 2026Priced priced an offering, S-1, ipo2 last Oct 19, 3:48 PM
Oct 8, 2026Effective registration went effective, S-1, ipo2 last Oct 19, 3:48 PM
Oct 8, 2026Upsize (MEF) filed to upsize an offering (MEF), S-12 last Oct 19, 3:48 PM
Sep 18, 2026New filing filed a new registration, S-1, ipo2 last Oct 19, 3:48 PM

A registration (S-1 or S-3) is permission to sell new shares later; effective means the SEC cleared it; a pricing or a 424B supplement means shares are being sold now; an MEF adds shares to a sale in progress. New shares sold into the market dilute existing holders.

All recent offering events